AGO Study Group
23 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer (NCT05009082) | AGO Study Group | 2022-09-13 |
Track AGO Study Group automatically
Every clearance here is in the API, with alerts when new ones post.